2021
Efficacy and safety of three active doses of onabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children: Results of a randomized controlled clinical trial
Austin P, Franco I, Dobremez E, Kroll P, Titanji W, Geib T, Jenkins B, Hoebeke P. Efficacy and safety of three active doses of onabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children: Results of a randomized controlled clinical trial. Toxicon 2021, 190: s6. DOI: 10.1016/j.toxicon.2020.11.352.Peer-Reviewed Original Research
2020
751 Efficacy and safety of three active doses of onabotulinum toxin A for the treatment of neurogenic detrusor overactivity in children: Results of a randomized controlled clinical trial
Hoebeke P, Austin P, Franco I, Dobremez E, Kroll P, Titanji W, Geib T, Jenkins B. 751 Efficacy and safety of three active doses of onabotulinum toxin A for the treatment of neurogenic detrusor overactivity in children: Results of a randomized controlled clinical trial. European Urology Open Science 2020, 19: e1147. DOI: 10.1016/s2666-1683(20)33351-6.Peer-Reviewed Original Research